1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Alexion Pharmaceuticals Inc (ALXN) EVP, Chief Compliance Officer Indrani Lall Franchini Sold $785,971 of Shares

June 09, 2020 | About:

EVP, Chief Compliance Officer of Alexion Pharmaceuticals Inc (30-Year Financial, Insider Trades) Indrani Lall Franchini (insider trades) sold 6,853 shares of ALXN on 06/08/2020 at an average price of $114.69 a share. The total sale was $785,971.

Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Alexion Pharmaceuticals Inc has a market cap of $25.61 billion; its shares were traded at around $115.99 with a P/E ratio of 10.92 and P/S ratio of 4.90. Alexion Pharmaceuticals Inc had annual average EBITDA growth of 27.30% over the past ten years. GuruFocus rated Alexion Pharmaceuticals Inc the business predictability rank of 3-star. GuruFocus has detected 1 severe warning sign with Alexion Pharmaceuticals Inc. .

Directors and Officers Recent Trades:

  • EVP, Chief Compliance Officer Indrani Lall Franchini sold 6,853 shares of ALXN stock on 06/08/2020 at the average price of $114.69. The price of the stock has increased by 1.13% since.

For the complete insider trading history of ALXN, click here


Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

pascal.van.garsseHigh FCF-M2
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)